Embody vs Willow: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent researchHow we rank →

Willow beats Embody overall, scoring 8.2/10 vs 7.3/10. Choose Embody for people who want the oral tirzepatide gum, or who'll pick the. Choose Willow for users who want comprehensive clinical support with flexibili.

A side-by-side comparison of Embody and Willow covering pricing, scores, medication types, insurance, and more to help you decide.

Embody

#38 of 48
7.3/10

Online weight-loss program that ships compounded GLP-1 medication to your door. Run by Modern Metabolic Medicine, Inc. and prescribed through CareGLP Affiliated P.C.s, their network of licensed doctors. Two pricing plans run side by side: a promo plan starting at $99/mo for semaglutide (or $149/mo for tirzepatide) that jumps after month 1, and 'Embody Flat' at $299/mo that doesn't go up. Their standout: oral tirzepatide gum, for people who don't want to inject.

Visit Embody
Higher Rated

Willow

#8 of 48
8.2/10

Personalized GLP-1 weight loss with ongoing clinical support. Compounded semaglutide and tirzepatide only — Willow explicitly does not prescribe brand-name Wegovy or Zepbound. Added oral compounded semaglutide tablets as a non-injectable option.

Visit Willow
FeatureEmbodyWillow
Our Score7.3/108.2/10
Starting Price$299/mo$299/mo
Medication TypeCompoundedCompounded
Insurance AcceptedNoNo
Best ForPeople who want the oral tirzepatide gum, or who'll pick the $299/mo flat plan with eyes open instead of the teaser planUsers who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes
Ranking#38#8

Pros & Cons Compared

Embody

Pros

  • +Cheap first month — $99 for semaglutide or $149 for tirzepatide. Among the lowest entry prices in the category.
  • +Oral tirzepatide gum is rare. Real option for needle-phobic users. (How well it absorbs vs the FDA-approved injection isn't published.)
  • +'Embody Flat' plan is $299/mo flat with no surprise increases — predictable if you pick it from the start.
  • +100% money-back guarantee in writing: if you follow the program and don't see results in 6 months, they say they'll make it right.
  • +Replies to every negative Trustpilot review, usually within 24 hours.

Cons

  • Recurring complaint: people sign up at $149 month 1, get billed $299–$399 in month 2. Embody admits in replies that two plans exist (promo + flat) and the switchover isn't always clear at signup.
  • Trustpilot rating is 3.3 / 5 across 46 reviews — heavily split: 41% love it, 24% give 1 star. Price is the top complaint theme.
  • Embody won't tell you which pharmacy makes the medication — just 'multiple USA certified pharmacies.' This is the norm in the category — most major brands (Embody, Henry, Hims, Yucca, Eden) don't publicly name their pharmacy partners.
  • No HIPAA disclosure on their site (HIPAA is the federal law protecting your medical info — most telehealth providers publish a statement confirming they follow it).
  • Compounded medications only — no brand-name Wegovy, Zepbound, Mounjaro, or Ozempic available.
  • If you stop treatment and come back, Embody's doctors will likely restart you at the lowest dose (2.5mg). It's their safety policy — some users find it overly cautious.

Willow

Pros

  • +Includes monthly provider check-ins and dose adjustments at no extra cost
  • +Offers both injectable AND oral compounded semaglutide — one of few platforms with a daily oral tablet option
  • +$299/mo all-in for compounded semaglutide with monthly provider support
  • +90%+ patient retention rate after 3 months per their published outcomes data

Cons

  • Compounded-only — no brand-name Wegovy or Zepbound through the platform
  • Tirzepatide pricing reaches $499-$524 at higher doses — starting dose is $399/mo
  • Cash-pay only — no insurance billing, though they provide superbills for FSA/HSA
  • Founded in 2024 — less track record than Ro or Hims, though growth has been fast

Our Verdict

Willow edges out Embody with a score of 8.2/10 vs 7.3/10. Choose Embody if you want: people who want the oral tirzepatide gum, or who'll pick the $299/mo flat plan with eyes open instead of the teaser plan. Choose Willow if you want: users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes.

Still undecided? Editor's #1 Overall Pick

Eden Health GLP-1

$249/mo · 8.9/10 · Both

If neither Embody nor Willow feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Eden Health GLP-1 — strongest balance of clinical oversight, transparent pricing, and verified availability.

Try Embody

Starting at $299/mo

Visit Embody

Try Willow

Starting at $299/mo

Visit Willow

Related comparisons

Other matchups readers comparing Embody or Willow tend to look at next.

Top Picks

Four programs our readers click through most.

Eden Health GLP-1

8.9/10
$249/mo·Brand & Compounded

Embody

7.3/10
$299/mo·Compounded

Gala

7.2/10
$149/mo·Brand & Compounded

Affiliate links — we earn a commission at no extra cost to you. Selection reflects what readers convert through, not editorial endorsement. Full ranking + methodology at glp1picks.com.